New York Updates

New York Updates

Key Takeaways

  • The RFA-2 form has been modified to better align with the process for resolving payer PAR denials. The updated version of Form RFA-2 is available as of today (12/4/2023). The prior version will continue to be accepted for 30 calendar days until 1/3/2024.
  • If the provider escalates a PAR denial for Level 3 review, any determination issued is final and not subject medical necessity review. Also, the payer may not dispute payment based on medical necessity.?
  • In instances where the claim administrator has raised the issue regarding condition or unestablished body part, payment for any services provided in relation to this condition or body part are not guaranteed by the Notice of Resolution.
  • Additionally, any dispute for payment related to the issue of causal relationship raised by the payer (Form C-8.1B) after the treatment is rendered may be resolved in favor of the payer.

Other Form Updates

The Board periodically releases new versions of forms. As such, the Board will only accept older versions of the forms listed below until January 31, 2024.

  • C-32 (4/21) - Waiver Agreement - Section 32 WCL
  • C-32AF (12-21) - Carrier's/Self-Insured Employer's Affirmation
  • C-32E (7/19) - Section 32 - Electronic Signature
  • C-32-I (6/20) - Settlement Agreement - Section 32 WCL Indemnity Only Settlement Agreement
  • C-300.5 (10/16) - Stipulation
  • C-312.5 (12/10) - Agreed Upon Findings And Awards For Proposed Conciliation Decision (Represented Claimants Only)
  • DB-451 (5/19) - Notice of Total or Partial Rejection of Claim for Disability Benefits
  • OC-400.5 (6-13) - Attorney/Representative's Certification of Form C-3 or Notice of Controversy
  • OC-400.17 (8/20) - Attorney/Licensed Representative Request to Withdraw from Representation
  • OC-406 (1/18) - Notice of Retainer and Appearance on Behalf of Employer

If you submit an older version of one of these forms after January 31, 2024, Conduent will send you a letter advising that you submitted an older version until the end of February (30 days after the deadline).?

要查看或添加评论,请登录

Alex O'Neal的更多文章

  • Medication PARs: Payer Beware

    Medication PARs: Payer Beware

    Some concerning medication PAR scenarios are beginning to reveal themselves. Our clinical team is identifying them and…

  • New York PAR Updates

    New York PAR Updates

    The WCB held a webinar on 3/27/2024 to keep payers updated. Below are key takeaways.

  • Tennessee Updates - 3/14/24

    Tennessee Updates - 3/14/24

    On 3/13/2024, The Bureau of Workers’ Compensation held their quarterly Medical Advisory Committee meeting. Be Aware FDA…

  • WCRI UR Notes

    WCRI UR Notes

    WCRI just released its annual Medical Cost Containment Inventory for 2024. Below are simple takeaways worth knowing…

    1 条评论
  • OnBoard Updates - 1/31/2024

    OnBoard Updates - 1/31/2024

    The New York WCB has provided some new updates. As always, here’s what you need to know: Current Takeaways The backlog…

  • Massachusetts UR - What You Must Know

    Massachusetts UR - What You Must Know

    Massachusetts has some unique rules when it comes to UR. The Department of Industrial Accidents (DIA) conducts very…

    3 条评论
  • PAR Updates - 10/26/2023

    PAR Updates - 10/26/2023

    On 10/25/2023, the Board held a webinar to provide updates and answer questions. Takeaways The Board clarified that…

  • Major NY PAR Update

    Major NY PAR Update

    I’ve spoken routinely about some highly requested changes that will occur in the future. The time has come.

    1 条评论
  • TX Drug Formulary Outcomes

    TX Drug Formulary Outcomes

    The Texas Division of Workers’ Compensation released its 2023 Pharmacy Cost and Utilization Report Texas was early onto…

  • Latest In Tennessee UR

    Latest In Tennessee UR

    The TN Bureau of Workers’ Compensation held their quarterly Medical Advisory Meeting (MAC) on 9/5/2023. As always…

    2 条评论

社区洞察

其他会员也浏览了